WallStreetZenWallStreetZen

NASDAQ: NUVL
Nuvalent Inc Stock Ownership - Who owns Nuvalent?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nuvalent Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Henry E. PelishChief Scientific Officer2025-06-06100$29.33
$2.93kBuy
Henry E. PelishChief Scientific Officer2025-06-06100$27.85
$2.79kBuy
Henry E. PelishChief Scientific Officer2025-06-06200$79.82
$15.96kSell
Darlene NociChief Development Officer2025-05-292,129$14.40
$30.66kBuy
Darlene NociChief Development Officer2025-05-29563$71.67
$40.35kSell
Darlene NociChief Development Officer2025-05-293,437$71.25
$244.89kSell
Darlene NociChief Development Officer2025-05-291,871$27.85
$52.11kBuy
James Richard PorterPresident and CEO2025-05-1511,489$69.99
$804.12kSell
James Richard PorterPresident and CEO2025-05-1515,176$69.28
$1.05MSell
James Richard PorterPresident and CEO2025-05-15335$70.77
$23.71kSell

1 of 21

NUVL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NUVL insiders and whales buy or sell their stock.

NUVL Shareholders

What type of owners hold Nuvalent Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn25.96%18,643,523$1.46BInsider
Deerfield Management Company LP Series C25.05%17,991,024$1.41BInstitution
Fmr LLC13.84%9,937,193$777.49MInstitution
Paradigm Biocapital Advisors LP7.34%5,269,433$412.28MInstitution
Vanguard Group Inc6.18%4,439,838$347.37MInstitution
Blackrock Inc5.22%3,748,361$293.27MInstitution
Commodore Capital LP2.58%1,855,000$145.14MInstitution
Matthew Shair2.29%1,643,719$128.60MInsider
Perceptive Advisors LLC2.28%1,633,968$127.84MInstitution
Price T Rowe Associates Inc2.02%1,450,602$113.50MInstitution

1 of 3

NUVL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NUVL75.11%24.89%Net SellingNet Buying
IONS96.72%3.28%Net SellingNet Buying
TGTX55.61%44.39%Net Selling
TLX0.01%0.00%
AXSM70.09%29.91%Net BuyingNet Selling
View Top Biotech Stocks

Nuvalent Stock Ownership FAQ

Who owns Nuvalent?

Nuvalent (NASDAQ: NUVL) is owned by 100.16% institutional shareholders, 33.20% Nuvalent insiders, and 0.00% retail investors. James E. Flynn is the largest individual Nuvalent shareholder, owning 18.64M shares representing 25.96% of the company. James E. Flynn's Nuvalent shares are currently valued at $1.46B.

If you're new to stock investing, here's how to buy Nuvalent stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.